Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction [Phase 3]
Phase 3 study of vortioxetine 10 mg and 20 mg for major depressive disorder with sexual dysfunction has completed. Results have been posted.
-
CLINICAL_TRIALS research · 2014-10-09Clinical Trial Update: The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients [Phase 4]
Phase 4 clinical trial update evaluating whether escitalopram can prevent depression and related emotional disorders in patients after acute…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Accelerated rTMS for Treatment-Resistant Major Depression [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluating accelerated repetitive transcranial magnetic stimulation for treatment-resistant major depressive diso…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Improvement and Mechanism of Wheel-chair Music Aerobic Exercise on Depression and Insomnia Among the Elderly in Long-term Care Facilities [NA]
A clinical trial update evaluating whether wheelchair-accessible music-based aerobic exercise improves depression and insomnia in elderly re…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Mentalization - Based Treatment: Adolescents With Co-morbid Depression and Personality Disorder [NA]
Update on a clinical trial evaluating Mentalization-Based Treatment for adolescents with co-morbid depression and personality disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Clinical Trials of Two Non-drug Treatments for Chronic Depression [NA]
The document reports the completion of clinical trials evaluating two non-drug treatments for chronic depression.
-
FDA approval · 2014-09-30FDA Approved: REMERON — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for REMERON (mirtazapine) filed by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder [Phase 4]
A Phase 4 clinical trial update examining how inflammatory factors and insulin resistance relate to Major Depressive Disorder.
-
FDA approval · 2014-09-26FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for duloxetine from Zydus Lifesciences Limited under an ANDA. The approval involves changes to the a…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women With Depressive Symptoms [NA]
A completed clinical trial evaluating the effects of breathing training on psychosocial functioning and heart rate variability in postmenopa…
-
CLINICAL_TRIALS withdrawal · 2014-09-26Clinical Trial Update: Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women With Depressive Symptoms-2 [NA]
A clinical trial evaluating breathing training for psychosocial functioning and heart rate variability in postmenopausal women with depressi…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients [Phase 4]
Phase 4 clinical trial evaluating a collaborative care program to improve treatment of depression and anxiety disorders in patients with hea…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder [Phase 4]
This is an update on a Phase 4 MRI study evaluating cognitive-behavior therapy for major depressive disorder. The sponsor is Nanjing Medical…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression [Phase 4]
A Phase 4 trial evaluated adding antidepressants to fingolimod in patients with relapsing-remitting multiple sclerosis and depression; the s…
-
FDA approval · 2014-09-24FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion hydrochloride (Apnar Pharma LP) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Homeopathic Treatment for Depression in Peri- and Postmenopausal Women [Phase 2]
Phase 2 clinical trial evaluating homeopathic treatment for moderate depression in peri- and postmenopausal women; the study completed and r…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression [Phase 2]
Phase 2 clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for panic disorder with comorbid major depressive diso…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression [Phase 1]
Phase I dose-escalation study of PDC-1421 capsule targeting in major depressive disorder completed with results posted in 2014.
-
FDA approval · 2014-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals, enabling a generic venlafaxine product through an ANDA s…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Accelerated Transcranial Magnetic Stimulation (TMS) for Depression [Phase 1]
Phase 1 study of accelerated Transcranial Magnetic Stimulation (TMS) for depression has been completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Cost-effectiveness of a Non-Pharmacological Treatment (Active Monitoring) vs. a Pharmacological Treatment for Major Depression in Primary Care.
The document reports on a clinical trial evaluating the cost-effectiveness of active monitoring versus pharmacological treatment for major d…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: PET Biomarkers in Treatment Resistant Depression [Phase 4]
Phase 4 clinical trial update on PET biomarkers in treatment-resistant depression (Major Depressive Disorder); the study was terminated and …
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial [NA]
The RESPECT-D-E trial evaluating enhanced collaborative depression treatment in primary care has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression [NA]
A completed study evaluated adding Wuling Capsule to standard therapy for patients with epilepsy and depression.
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: ICU Family Communication Study [Phase 3]
Phase 3 clinical trial update on the ICU Family Communication Study; the study has completed. It investigates ICU-family communication and a…